Study Reports E-Cigarette Aerosols Trigger Mitochondrial Dysfunction and Ferroptosis in Alveolar Cells

Researchers found that cinnamon roll-flavored e-cigarette aerosols with nicotine induce mitochondrial DNA damage and trigger cell-death pathways in human alveolar cells, identifying potential therapeutic targets for vaping-associated lung injury.

A study published in the American Journal of Respiratory Cell and Molecular Biology evaluated the cellular impacts of cinnamon roll-flavored e-cigarette aerosols containing nicotine on primary human alveolar type II (ATII) cells and precision-cut lung slices.

The researchers reported that exposure to the aerosols led to mitochondrial DNA damage and lipid peroxidation, alongside reduced levels of the mitochondrial respiratory chain subunits NDUFS1 and UQCRC2, indicating disruption of complexes I and III.

The cellular response was characterized by elevated markers of autophagy (LAMP2 and LC3B) and a classic signature of ferroptosis, including decreased GPX4 and increased ACSL4 protein expression.

In vivo experiments in wild-type mice confirmed a similar decrease in respiratory chain subunits, while experiments in DJ-1 knockout mice demonstrated reduced surfactant protein C (SP-C) expression and increased mitochondrial superoxide production, pointing to a protective role for DJ-1.

The research provides a concrete mechanistic link between specific e-cigarette aerosol formulations and direct mitochondrial damage, challenging assumptions regarding the safety of vaping flavorings.

Characterizing the molecular cascade involving GPX4, ACSL4, and DJ-1 provides clear pharmacological targets for mitigating vaping-associated lung injury.

Understanding these pathways is highly relevant to respiratory longevity, as ATII cells are vital for surfactant production and the regeneration of the alveolar epithelium.

These mechanistic insights may direct drug discovery efforts toward mitochondrial protectants and ferroptosis inhibitors to treat acute and chronic respiratory conditions.

The identified biomarkers of mitochondrial toxicity could influence future regulatory assessments and safety criteria for inhalable consumer products.

Subsequent preclinical evaluations of ferroptosis inhibitors or mitochondrial-targeted therapies to prevent or reverse e-cigarette-induced alveolar epithelial damage.